Today after years of following the company Advanced Cell Technology (ACT), I finally bought stock (ACTC) in it. Why? As a stem cell researcher myself working on human ES cells, iPS cells, and many other types of stem cells, I have been following ACT for years, but have never pulled the trigger to buy their stock….until […]
Why I finally bought stock in Advanced Cell Technology Read More »
In June 2011 I did a post about genomics and its growing importance both for science and society. The stem cell field has a very rapidly accelerating genomic component as well. I went so far as to call it a revolution and I still believe that is not an exaggeration. CIRM has rightly recognized the
CIRM goes genomic: the California stem cell agency focuses on DNA Read More »
Last year around this time I presented my first stem cell awards of the year, in that case for 2010. You can see whom I thought deserved awards here. Now it is time for our 2011 stem cell awards. These awards reflect my opinions and those not mentioned will hopefully forgive me as there is
Stem Cell Awards for 2011 Read More »
Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that
The day after Geron news: a realistic outlook for the stem cell field Read More »
Many of you may have heard that there is a Vatican stem cell meeting . Today the Vatican held the first day of its adult stem cell conference. Embryonic stem cells remained not surprisingly uninvited. This conference is an unprecedented event in the thousands of years of history of The Church so not surprisingly many
What are the goals of the Vatican stem cell meeting and why no press releases so far? Read More »
In mid-November the Catholic Church, in fact the Vatican itself, will do something it has never done before in its very long existence. It will hold a conference on stem cells. Perhaps equally unusual and of interest is the fact that the basis for this conference is a $1 million (USD) gamble by the Vatican
More on the Vatican $1 million gamble on NeoStem and their upcoming conference in Rome Read More »
Why does it worry me that the Vatican is having a stem cell conference? One of the hallmarks of Democracy is separation of church and state. When states mix religion into politics and government, the results have during human history been disastrous. Equally dismal has been the relationship between religion and science. Ever since the
The Vatican Stem Cell Meeting…is mixing religion and science a good idea? Read More »
There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court
Anti-cure impact of Errant EU stem cell patent decision Read More »
I have posted before about publishing trends in the iPS cell field here and in here…. but where do things stand today? Here, I provide an important update. What’s going on now? Here I provide answers to the key questions. How many papers are there on iPS cells? An interesting and unexpected trend for
Everything you need to know about publishing in the iPS cell field Read More »
How can I make money from stem cells? Someone recently asked me this question and more often I get asked “Which stem cell companies do YOU like as a stem cell scientist?” Just today an article went out that said that the global market for stem cell products will be $65 billion by 2015. That’s
How to make money from stem cells Read More »